Literature DB >> 24399701

Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups.

Rebecca R Andridge1, Abigail B Shoben, Keith E Muller, David M Murray.   

Abstract

Participants in trials may be randomized either individually or in groups and may receive their treatment either entirely individually, entirely in groups, or partially individually and partially in groups. This paper concerns cases in which participants receive their treatment either entirely or partially in groups, regardless of how they were randomized. Participants in group-randomized trials are randomized in groups, and participants in individually randomized group treatment trials are individually randomized, but participants in both types of trials receive part or all of their treatment in groups or through common change agents. Participants who receive part or all of their treatment in a group are expected to have positively correlated outcome measurements. This paper addresses a situation that occurs in group-randomized trials and individually randomized group treatment trials-participants receive treatment through more than one group. As motivation, we consider trials in The Childhood Obesity Prevention and Treatment Research Consortium, in which each child participant receives treatment in at least two groups. In simulation studies, we considered several possible analytic approaches over a variety of possible group structures. A mixed model with random effects for both groups provided the only consistent protection against inflated type I error rates and did so at the cost of only moderate loss of power when intraclass correlations were not large. We recommend constraining variance estimates to be positive and using the Kenward-Roger adjustment for degrees of freedom; this combination provided additional power but maintained type I error rates at the nominal level.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  group-randomized trial; individually randomized group treatment trial; intraclass correlation; mixed models

Mesh:

Year:  2014        PMID: 24399701      PMCID: PMC4013262          DOI: 10.1002/sim.6083

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

1.  A covariance estimator for GEE with improved small-sample properties.

Authors:  L A Mancl; T A DeRouen
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  Small-sample adjustments for Wald-type tests using sandwich estimators.

Authors:  M P Fay; B I Graubard
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

3.  A Monte Carlo study of alternative responses to intraclass correlation in community trials. Is it ever possible to avoid Cornfield's penalties?

Authors:  D M Murray; P J Hannan; W L Baker
Journal:  Eval Rev       Date:  1996-06

4.  Small-sample adjustments in using the sandwich variance estimator in generalized estimating equations.

Authors:  Wei Pan; Melanie M Wall
Journal:  Stat Med       Date:  2002-05-30       Impact factor: 2.373

5.  Methods to reduce the impact of intraclass correlation in group-randomized trials.

Authors:  David M Murray; Jonathan L Blistein
Journal:  Eval Rev       Date:  2003-02

6.  The use of random effects models to allow for clustering in individually randomized trials.

Authors:  Katherine J Lee; Simon G Thompson
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

7.  Design and analysis of clinical trials with clustering effects due to treatment.

Authors:  Chris Roberts; Stephen A Roberts
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

8.  Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.

Authors:  Michael Proschan; Dean Follmann
Journal:  Stat Med       Date:  2008-03-15       Impact factor: 2.373

Review 9.  Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.

Authors:  Sherri L Pals; David M Murray; Catherine M Alfano; William R Shadish; Peter J Hannan; William L Baker
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

Review 10.  Ignoring the group in group-level HIV/AIDS intervention trials: a review of reported design and analytic methods.

Authors:  Sherri L Pals; Ryan E Wiegand; David M Murray
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

View more
  7 in total

Review 1.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

Review 2.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 2-Analysis.

Authors:  Elizabeth L Turner; Melanie Prague; John A Gallis; Fan Li; David M Murray
Journal:  Am J Public Health       Date:  2017-05-18       Impact factor: 9.308

3.  Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.

Authors:  Monica Taljaard; Fan Li; Bo Qin; Caroline Cui; Leyi Zhang; Stuart G Nicholls; Kelly Carroll; Susan L Mitchell
Journal:  Clin Trials       Date:  2021-11-29       Impact factor: 2.486

4.  Influential methods reports for group-randomized trials and related designs.

Authors:  David M Murray
Journal:  Clin Trials       Date:  2022-01-06       Impact factor: 2.599

5.  Power and Sample Size for Fixed-Effects Inference in Reversible Linear Mixed Models.

Authors:  Yueh-Yun Chi; Deborah H Glueck; Keith E Muller
Journal:  Am Stat       Date:  2018-06-04       Impact factor: 8.710

6.  Accounting for Context in Randomized Trials after Assignment.

Authors:  C Hendricks Brown; Donald Hedeker; Robert D Gibbons; Naihua Duan; Daniel Almirall; Carlos Gallo; Inger Burnett-Zeigler; Guillermo Prado; Sean D Young; Alberto Valido; Peter A Wyman
Journal:  Prev Sci       Date:  2022-09-09

7.  Coping with persistent pain, effectiveness research into self-management (COPERS): statistical analysis plan for a randomised controlled trial.

Authors:  Brennan C Kahan; Karla Diaz-Ordaz; Kate Homer; Dawn Carnes; Martin Underwood; Stephanie Jc Taylor; Stephen A Bremner; Sandra Eldridge
Journal:  Trials       Date:  2014-02-15       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.